Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models-Reference-Cited by-同舟云学术

Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models

Published:2017-08-26 Issue:11 Volume:141 Page:2348-2358
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Esaki Shinichi¹²,Nigim Fares¹,Moon Esther¹,Luk Samantha¹,Kiyokawa Juri¹,Curry William¹,Cahill Daniel P.¹,Chi Andrew S.³,Iafrate A. John⁴,Martuza Robert L.¹,Rabkin Samuel D.¹,Wakimoto Hiroaki¹^ORCID

Affiliation:

1. Department of NeurosurgeryMassachusetts General Hospital, Harvard Medical SchoolBoston MA

2. Department of OtolaryngologyHead and Neck Surgery, Nagoya City University Graduate School of Medical Sciences and Medical SchoolNagoya Japan

3. Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical CenterNew York NY

4. Department of PathologyMassachusetts General Hospital, Harvard Medical SchoolBoston MA

Funder

National Institutes of Health

American Brain Tumor Association

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30929

Reference55 articles.

1. Malignant Gliomas in Adults

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

4. Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

5. Standards of care for treatment of recurrent glioblastoma—are we there yet?

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

2. The TGF-β Family in Glioblastoma;International Journal of Molecular Sciences;2024-01-15

3. Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice;Frontiers in Immunology;2024-01-11

4. Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies;Cancer Letters;2023-09

5. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy;Journal of Translational Medicine;2023-07-25